Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Insulet

Biotech & Life Sciences · Acton, United States · Founded 2000 · IPO 2007 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$11B
Market cap · Apr/2026
Revenue
$2.71B
Latest reported FY

Investors

12 investors on Insulet's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage
Prism Venture Management
Series B+ 11 investors entered at this stage
Longitude Capital
SightLine Partners
MedVenture Associates
OrbiMed
Oakwood Medical Investors
Red Abbey Venture Partners
Alta Partners
Versant Ventures
SV Health Investors
Aphelion Capital
TIAA

Global footprint

Where Insulet has talent and traffic

AI talent share
0.3% of workforce is AI talent
(16 of 5,072 staff)
Core AI70.14%
Other AI90.18%
Non-AI workforce5,05699.68%
Web traffic by country
130K monthly visits
across markets
🇺🇸 United States49.1%
🇲🇽 Mexico32.8%
🇬🇧 United Kingdom3.9%
🇨🇦 Canada2.1%
🇦🇺 Australia1.9%
Top 5 markets shown

Patent intelligence

$502M patent portfolio · 606 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$502M
4.4% of market cap · comparable to top peer NovoCure ($409M)
606 active patent families
Where Insulet innovates Biomedical engineeringIntensive care medicineDrug deliveryPharmaceutical drugInsulin humulin
Above peer median on Strategic

Quality vs same-sector peers

Insulet on the five Patsnap quality dimensions

Insulet in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Insulet concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Insulet and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Insulet on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo